Bank of New York Mellon Corp - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 116 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q2 2023$11,649
+15.7%
14,3820.0%0.00%
Q1 2023$10,067
-0.8%
14,382
+0.0%
0.00%
Q4 2022$10,153
-53.8%
14,3810.0%0.00%
Q3 2022$22,000
-33.3%
14,381
-56.1%
0.00%
Q2 2022$33,000
-78.8%
32,788
-69.9%
0.00%
Q1 2022$156,000
-70.9%
108,965
+6.2%
0.00%
Q4 2021$536,000
-13.4%
102,603
-3.5%
0.00%
Q3 2021$619,000
-25.5%
106,305
+3.1%
0.00%
Q2 2021$831,000
-16.6%
103,158
-13.9%
0.00%
Q1 2021$997,000
+9.7%
119,839
-0.0%
0.00%
Q4 2020$909,000
-35.1%
119,862
-8.8%
0.00%
Q3 2020$1,401,000
-30.2%
131,429
-0.7%
0.00%
-100.0%
Q2 2020$2,006,000
+99.6%
132,318
+9.6%
0.00%
Q1 2020$1,005,000
-50.1%
120,755
+1.4%
0.00%
-100.0%
Q4 2019$2,013,000
-4.8%
119,111
+4.6%
0.00%0.0%
Q3 2019$2,115,000
-19.8%
113,891
-1.2%
0.00%0.0%
Q2 2019$2,637,000
+3.9%
115,229
-4.6%
0.00%0.0%
Q1 2019$2,538,000
+83.2%
120,798
+0.3%
0.00%
Q4 2018$1,385,000
-50.2%
120,430
-0.6%
0.00%
-100.0%
Q3 2018$2,780,000
+0.1%
121,129
-2.7%
0.00%0.0%
Q2 2018$2,777,000
-6.9%
124,547
-4.6%
0.00%0.0%
Q1 2018$2,983,000
-11.3%
130,535
+1.7%
0.00%0.0%
Q4 2017$3,364,000
+18.1%
128,395
+1.2%
0.00%0.0%
Q3 2017$2,848,000
-33.6%
126,863
-19.1%
0.00%0.0%
Q2 2017$4,288,000
+49.2%
156,779
+32.0%
0.00%0.0%
Q1 2017$2,874,000
+16.4%
118,741
-0.2%
0.00%0.0%
Q4 2016$2,469,000
-20.3%
118,988
+4.7%
0.00%0.0%
Q3 2016$3,099,000
+69.5%
113,664
-10.5%
0.00%0.0%
Q2 2016$1,828,000
-0.9%
127,016
-1.0%
0.00%0.0%
Q1 2016$1,844,000
-30.5%
128,327
+3.9%
0.00%0.0%
Q4 2015$2,654,000
+50.3%
123,491
+13.1%
0.00%0.0%
Q3 2015$1,766,000
-53.1%
109,149
-25.2%
0.00%0.0%
Q2 2015$3,765,000
+35.2%
145,869
+17.9%
0.00%0.0%
Q1 2015$2,785,000
+16.6%
123,751
-0.5%
0.00%0.0%
Q4 2014$2,388,000
-10.1%
124,435
+0.7%
0.00%0.0%
Q3 2014$2,655,000
-56.9%
123,615
-47.8%
0.00%0.0%
Q2 2014$6,158,000
+248.3%
236,840
+192.1%
0.00%
Q1 2014$1,768,000
+124.7%
81,082
+25.7%
0.00%
Q4 2013$787,000
-46.0%
64,492
-40.7%
0.00%
Q3 2013$1,458,000
+250.5%
108,740
+112.0%
0.00%
Q2 2013$416,00051,2810.00%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Birchview Capital, LP 2,065,560$39,638,00023.01%
Selkirk Management LLC 165,700$3,180,0001.90%
Opaleye Management Inc. 100,000$1,919,0000.97%
LUCUS ADVISORS LLC 80,000$1,535,0000.68%
Miura Global Management 435,000$8,348,0000.63%
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP 276,549$5,307,0000.48%
Iguana Healthcare Management, LLC 50,000$960,0000.46%
BSW Wealth Partners 22,714$436,0000.35%
Harvest Capital Strategies LLC 90,000$1,727,0000.19%
FAIRFIELD, BUSH & CO. 35,100$674,0000.19%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders